E Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Sell |
16,160
-311
| -2% | -$12.3K | 0.03% | 202 |
|
|
2025
Q1 | $497K | Sell |
16,471
-397
| -2% | -$12K | 0.02% | 226 |
|
|
2024
Q4 | $590K | Buy |
16,868
+4,116
| +32% | +$144K | 0.03% | 204 |
|
|
2024
Q3 | $511K | Buy |
12,752
+2,497
| +24% | +$100K | 0.03% | 194 |
|
|
2024
Q2 | $489K | Buy |
10,255
+430
| +4% | +$20.5K | 0.03% | 179 |
|
|
2024
Q1 | $426K | Sell |
9,825
-40
| -0.4% | -$1.73K | 0.03% | 192 |
|
|
2023
Q4 | $499K | Sell |
9,865
-1,231
| -11% | -$62.3K | 0.03% | 169 |
|
|
2023
Q3 | $503K | Buy |
11,096
+108
| +1% | +$4.9K | 0.04% | 121 |
|
|
2023
Q2 | $451K | Sell |
10,988
-384
| -3% | -$15.8K | 0.04% | 129 |
|
|
2023
Q1 | $406K | Buy |
11,372
+100
| +0.9% | +$3.57K | 0.03% | 162 |
|
|
2022
Q4 | $426K | Buy |
11,272
+1,102
| +11% | +$41.6K | 0.04% | 168 |
|
|
2022
Q3 | $450K | Sell |
10,170
-2,427
| -19% | -$107K | 0.04% | 143 |
|
|
2022
Q2 | $466K | Buy |
12,597
+4,263
| +51% | +$158K | 0.04% | 157 |
|
|
2022
Q1 | $309K | Buy |
+8,334
| New | +$309K | 0.01% | 188 |
|